A detailed discussion on gynecology as a specialty between Prassan Vij, MD, and host Nachiket Bhatia, MD. They explore the rewards and challenges of this field, the importance…
Jennifer Lincoln, MD, a board-certified OBGYN, demonstrates a pelvic exam on a simulation model, explaining its components and purpose. She covers the external and internal anatomy assessed during…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that antenatal steroids seem safe and reduce adverse outcomes in preterm infants when the pregnancy is complicated by…
NEW YORK (Reuters Health) – The school performance at age 16 of children born to epileptic mothers correlates with their degree of exposure to anticonvulsant drugs in utero,…
NEW YORK (Reuters Health) – Pregnancy outcomes are improved for overweight women when they adopt a low-glycemic load diet compared with a low-fat diet, a Massachusetts-based group reports…
NEW YORK (Reuters Health) – Results of in vitro testing indicate that silver impregnation of urinary catheters has little effect on bacterial adherence, reinforcing findings from clinical studies…
NEW YORK (Reuters Health) – A dose-ranging study of onabotulinumtoxinA, better known as Botox, injected into the detrusor muscle for the treatment of refractory overactive bladder indicates that…
NEW YORK (Reuters Health) – Women who have undergone laparoscopic surgery for endometrioma have a reduced risk of recurrence when they take low-dose oral contraceptives, a Korean team…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
NEW YORK (Reuters Health) – Among women undergoing resection of endometrial polyps, the prevalence of malignant or premalignant polyps ranges from about 2% to 5%, with the higher…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
